KRAS and non-small cell lung carcinoma: AMG 510 is a novel, first-in-class, small molecule that specifically and irreversibly inhibits KRAS G12C by permanently locking it in an inactive GDP-bound state, and it demonstrated promising antitumor activity in patients with advanced NSCLC harbouring the KRAS G12C mutation (28).